Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 33342-106

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 33342-106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30s (30s Container)

Label for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets 200 mg/300 mg by Macleods Pharmaceuticals Limited. The film-coated tablets come in a 30-tablet package. The label includes dosage information, storage instructions, and manufacturer details for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd.*

FDA Label Image

Emtri (Structure Emtricitabine)

Chemical structure diagram of tenofovir disoproxil fumarate, showing the molecular arrangement of atoms including nitrogen, oxygen, fluorine, sulfur, and carbon atoms in a cyclic and linear configuration.*

FDA Label Image

Structure-tenofovir (Structure Tenofovir)

Chemical structure diagram of emtricitabine and tenofovir disoproxil fumarate, the active ingredients in the oral film-coated tablet by Macleods Pharmaceuticals Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.